Inncelerex specializes in supporting drug development across all stages, including: candidate selection, toxicology, pre-clinical, early clinical development, late-phase clinical trials, drug registration and post marketing requirements.
Our integration of scientific and regulatory expertise in clinical pharmacology, modeling and simulation, translational medicine, toxicology and pre-clinical safety offers comprehensive solutions which serve to enhance program design, execution and strategic decision-making.
Our ability to manage a broad spectrum of studies, including clinical pharmacology, pharmacometrics, pharmacodynamics, toxicology, and ADME studies, ensures program efficiency and precision.
Company Details
- Employees
- 3
- Founded
- -
- Address
- -, Jersey City,nj 07302,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.inncelerex.com/
- Keywords
- Pharmacokinetics, Clinical Pharmacology, Pharmacometrics, Pharmacodynamics, Modeling & Simulation, Early Clinical Development, Pharmaceutical, R&D, Research, Quantitative Clinical Pharmacology, PKPD, PBPK, Toxicology, Pre-clinical, Safety, Phase 1, Physiologically-based Pharmacokinetics.
- HQ
- Jersey City, NJ
Inncelerex Questions
Inncelerex's website is https://www.inncelerex.com/
Inncelerex's LinkedIn profile is https://www.linkedin.com/company/inncelerex
Inncelerex has
3 employees.
View email and phone details for 3
employees at Inncelerex.
Inncelerex's industry is
Biotechnology Research
Inncelerex's top competitors are
Neuronasal Llc,
A2-Ai,
Modeling Great Solutions,
Blue Ridge Biopharma, Llc,
Iqvia,
Nanonewron,
Praxis Precision Medicines, Inc.,
Revolution Medicines,
Latigo Biotherapeutics, Inc.,
Pharmia.
Inncelerex's categories are Biotechnology Research
Inncelerex's founding year is 2015
